Browse > Article
http://dx.doi.org/10.5392/JKCA.2021.21.04.487

Factors Affecting Length of Stay and Death in Tuberculosis Patients(2008-2017): Focus on the Korean National Hospital Discharge In-depth Injury Survey  

Lee, Hyun-Sook (국립공주대학교 보건행정학과)
Kim, Sang-Mi (전주대학교 보건관리학과)
Publication Information
Abstract
The purpose of this study is to identify factors affecting length of stay(LOS) and death in tuberculosis(TB) patients by disease type, patient characteristic, admission and disease characteristic, and hospital characteristic from 2008 to 2017. Survey data was using Korean national hospital discharge in-depth survey data produced by Korea Disease Control and Prevention Agency. Study subjects were 10,634 inpatients with TB(A15, A16, A17, A18, A19, U88.0, U88.1, U84.30, U84.31) and analyzed frequency, chi-square test, Fisher's exact test, and logistic regression by using STATA 13.0. As a study result, the type of TB(extrapulmonary TB, multidrug-resistant TB, extensively drug-resistant TB), sex(woman), age(35-49, 50-64, 65-74, 75 years old or older), admission type(outpatient department), CCI(1-2 point, 3 point over), hospital location(metropolitan city) and bed size(300-499, 500-999, over 1000) were significantly influence LOS. Also, the type of TB(extrapulmonary TB, extensively drug-resistant TB), sex(woman), age(50-64, 65-74, 75 years old or older), residence(small town/rural), admission type(outpatient department), CCI(1-2 point, 3 point over), hospital location(provincial) were significantly influence death. In conclusion, the existing tuberculosis management has been patient management with rapid diagnosis and treatment following early detection. But other studies should be carried out for the system that identifies and supports high-risk groups of the long-term length of stay in hospital or high mortality rates as a result of treatment.
Keywords
Tuberculosis; In-patient; Long-term Length of Stay; Death;
Citations & Related Records
연도 인용수 순위
  • Reference
1 World Health Organization, Global Tuberculosis Report 2019, World Health Organization, 2019.
2 질병관리청, 2019 결핵환자 신고현황 연보, 질병관리청, 2020.
3 질병관리청, 결핵진료지침, pp.7-8, 2017.
4 김희진, 이은표, 이경호, 김미현, 이진범, 김준현, 나경인, "건강검진 자료를 이용한 폐결핵 발생률 조사," 질병관리본부 결핵연구원, pp.1-6, 2011.
5 I. K. Holden, T. Lillebaek, P. H. Andersen, C. Wejse, I. S. Johansen, "Characteristics and Predictors for Tuberculosis related Mortality in Denmark from 2009 through 2014: A Retrospective Cohort Study," PLoS One, v.15, n.6, 2020 :e0231821. Published 2020 Jun 4. doi:10.1371/journal.pone.0231821 http://www.koreacontents.or.kr/~paper.html, 2017.03.28.   DOI
6 윤경일, "결핵 입원환자의 치료결과에 영향을 미치는 환자 특성과 의료기관 특성," 한국병원경영학회지, 제19권, 제2호, pp.44-54, 2014.
7 질병관리청, 결핵진료지침, pp.201-205, 2017.
8 질병관리청, 결핵진료지침, p.98, 2020.
9 S. M. Marks, J. Flood, B. Seaworth, Y. Hirsch-Moverman, L. Armstrong, S. Mase, K. Salcedo, P. Oh, E. A. Graviss, P. W, Colson, L. Armitige, M. Revuelta, K. Sheeran, and TB Epidemiologic Studies Consortium, "Treatment Practices, Outcomes, and Costs of Multidrug-resistant and Extensively Drug-resistant Tuberculosis, United States, 2005-2007," Emergency Infection Disorder, Vol.20, No.5, pp.812-821, 2014.   DOI
10 O. A. A. Ahmed, "Barriers Leading to Treatment Default among Tuberculosis Patients in Khartoum State, Sudan: a Qualitative Study," Clinic Medicine Investment, Vol.3, 2018.
11 통계청, 주요 인구지표, 2017.
12 최영순, 태윤희, 김지윤, "우리나라 결핵 환자의 치료 장기화와 다약제내성결핵 발생에 영향을 미치는 요인," 보건정보통계학회지, 제41권, 제3호, pp.344-350, 2016.
13 조승희, "2011년 취약계층 결핵검진결과 분석," 주간건강과 질병, 제5권, 제13호, pp.238-243, 2012.
14 김상미, 이현숙, 황슬기, "의료보장유형에 따른 폐결핵 입원환자의 재원기간과 치료결과 차이분석," 병원경영학회지, 제21권, 제4호, pp.48-50, 2016.
15 이현숙, 황슬기, 김상미, "결핵입원환자의 치료결과에 영향을 미치는 요인," 한국콘텐츠학회논문지, 제16권, 제10호, pp.196-199, 2016.   DOI
16 박재석, "노인 폐결핵의 치료," 대한내과학회지, 제75권, 제2호, pp.141-148, 2008.
17 M. U. Mushtaq, U. Shahid, H. M. Abdullah, A. Saeed, F. Omer, M. A. Shad, A. M. Siddiqui, and J. Akram, "Urban-rural Inequities in Knowledge, Attitudes and Practices regarding Tuberculosis in Two Districts of Pakistan's Punjab province," International Journal Equity Health. 2011. 2011 Feb 4;10:8. doi: 10.1186/1475-9276-10-8. PMID: 21294873; PMCID: PMC3045313.   DOI
18 김유미, 최윤경, 강성홍, 김원중, "지역사회획득 폐렴환자의 중증도 보정 재원일수 분석," 한국산학기술학회논문지. 제12권, 제3호, pp.1234-1243, 2011.   DOI
19 https://www.gov.kr/portal/service/serviceInfo/GMW000000220, 2020.09.10.
20 A. B. Flood, W. Ewy, W. R. Scott, W. H. Forrest, Jr, and B.W. Brown, Jr, "The Relationship between Intensity and Duration of Medical Services and Outcomes for Hospitalized Patients," Medical Care., Vol.17, No.11, pp.1088-1102, 1979.   DOI
21 https://knta.or.kr/tbInfo/tbCondition/tbCondition.asp
22 최홍조, 황수연, 김보은, 김현우, 유사라, 오경현, 김희진, 김혜영, "국내 결핵 신환자의 치료결과에 영향을 미치는 요인: 결핵신고자료 2014년 포호트 분석 결과," 대한결핵 및 호흡기학회 추계학술대회, p.75, 2017.
23 S. Mutembo, J. N. Mutanga, K. Musokotwane, C. Kanene, K. Dobbin, X. Yao, C. Li, V. C. Marconi, and C. C. Whalen, "Urban-rural Disparities in Treatment Outcomes among Recurrent TB Cases in Southern Province, Zambia," BMC Infection Disorder, Vol.19, No.1, p.1087, 2019.   DOI
24 이남준, 폐결핵환자의 사망과 관련된 요인: 환자-대조군 연구, 창원대학교 보건대학원, 석사학위논문, 2016.
25 S. P. Wright, D. Verouhis, G. Gamble, K. Swedberg, N. Sharpe, and R. N. Doughty, "Factors Influencing the Length of Hospital Stay of Patients with Heart Failure," Europe Journal Heart Fail, Vol.5, No.2, pp.201-209, 2003.   DOI
26 M. Sanchez-Rojas, E. M. Perez, A. M. Perez, S. V. Cifuentes, E. G. Villalba, M. Campoy, A. C. Sanchez, and E. B. Morell, "Factors Associated With a Long Mean Hospital Stay in Patients Hospitalized With Tuberculosis," Arch Bronconeumol, Vol.53, pp.409-410, 2003.   DOI
27 S. B. Marahatta, R. K. Yadav, D. Giri, S. Lama, K. R. Rijal, S. R. Mishra, A. Shrestha, P. R. Bhattrai, R. K. Mahato, and B. Adhikari, "Barriers in the Access, Diagnosis and Treatment Completion for Tuberculosis Patients in Central and Western Nepal: A Qualitative Study among Patients," Community Members and Health Care Workers, PLoS ONE, Vol.15, No.1, 2020 :e0227293. https://doi.org/10.1371/journal.pone.0227293   DOI
28 보건복지부, 결핵퇴치를 위한 범정부'결핵 예방관리강화대책'추진 보도자료, https://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&CONT_SEQ=349571 2021.1.1.
29 결핵예방법, https://www.law.go.kr/LSW/lsInfoP.do?efYd=20200912&lsiSeq=220877#0000
30 질병관리청, 국가결핵관리지침, p.21, 2018.
31 Yamaguti, Verena, Rijo, Rui, Crepaldi, Nathalia, Ruffino-Netto, Antonio, Carvalho, Isabelle, and Alves, Domingos. "Charlson Comorbidities Index Importance Evaluation as a Predictor to Tuberculosis Treatments Outcome in the State of Sao Paulo, Brazil. Procedia," Computer Science, Vol.138, pp.258-263, 2018.
32 질병관리청, 2016 퇴원손상심층조사, pp.29-36, 2019.
33 W. T. Yang, C. R. Gounder, T. Akande, J. W. De Neve, K. N. McIntire, A. Chandrasekhar, A. de Lima Pereira, N. Gummadi, S. Samanta, and A Gupta, "Barriers and Delays in Tuberculosis Diagnosis and Treatment Services: Does Gender Matter?," Tuberculosis Research Treatment. 2014;2014:461935. doi: 10.1155/2014/461935. Epub 2014 Apr 28. PMID: 24876956; PMCID: PMC4020203.   DOI
34 이아람, 결핵 치료 요법이 치료 완료 및 재발에 미치는 영향, 연세대학교, 석사학위논문, 2016.